sábado, 7 de marzo de 2026
Antibody–drug conjugates for bladder sparing: lessons from SURE-02 trial Kriti Mittala ∙ Monika Joshi ++++
Hormone therapy use and duration with postoperative radiotherapy for recurrent prostate cancer: an individual patient data meta-analysis
Prof Amar U Kishan, MDa,† aukishan@mednet.ucla.edu ∙ Yilun Sun, PhDf,† ∙ Prof Christopher C Parker, MDi,j ∙ Prof Paul Sargos, MDl ∙ Prof Matthew R Sydes, MSck ∙ Sylvie Chabaud, MScm ∙ et al.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00137-6/fulltext?dgcid=hubspot_email_conferencealerts_ascogu26&utm_campaign=conferencealerts&utm_medium=email&_hsenc=p2ANqtz-9mriL3plLkylsLbaF33DxEhEV-LqdYAziVUsAwc-AHB8dpEQCJaJzrhhV66PorEJVoyvwpjaHCt7QsslJ5QX7mJQaqtQ&_hsmi=405866764&utm_content=405866764&utm_source=hs_email
Neoadjuvant sacituzumab govitecan plus pembrolizumab, followed by adjuvant pembrolizumab, in patients with muscle-invasive bladder cancer (SURE-02): a single-arm, phase 2 study
Prof Andrea Necchi, MDa,h necchi.andrea@hsr.it ∙ Brigida A Maiorano, MD PhDa ∙ Joep J de Jong, MD PhDf ∙ James A Proudfoot, MScg ∙ Giuseppe Basileb ∙ Antonio Cigliola, MDa,h ∙ et al.
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(26)00050-1/abstract?utm_campaign=conferencealerts&utm_medium=email&dgcid=hubspot_email_conferencealerts_ascogu26&_hsenc=p2ANqtz-8T1rUw4SAYaW7eenOp1toFWU57cfzJ23QyYfNYUvTc1OY9gyQLcf3yB4HyPQU7Oo9PgYumga-2rkuG7kUKf4_JhjtP7w&_hsmi=405866764&utm_content=405866764&utm_source=hs_email
Impact of adding hormone therapy to postoperative radiotherapy in prostate cancer
Ana M Aparicio aaparicio@mdanderson.org ∙ Patrick G Pilié
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00368-5/abstract?utm_campaign=conferencealerts&utm_medium=email&dgcid=hubspot_email_conferencealerts_ascogu26&_hsenc=p2ANqtz-_OTjl1tQq-FhSSLyHSfGFv5YTXOXhdcsXzQ6df-6lbBj_TixXgr2VkloC_Mz6S_0pXvBcEOtB5ndM8nefNIhFxM8jz-A&_hsmi=405866764&utm_content=405866764&utm_source=hs_email
Antibody–drug conjugates for bladder sparing: lessons from SURE-02 trial
Kriti Mittala ∙ Monika Joshi
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(26)00073-2/abstract?utm_campaign=conferencealerts&utm_medium=email&dgcid=hubspot_email_conferencealerts_ascogu26&_hsenc=p2ANqtz-912qADVDXDfTg2wXN-BkvUctB7hgmGNK8MwoWMJz-S5DPc9kMybsvvigMsU5KyGLtlvAll_wu1sCURjaRpM8RENE7l2g&_hsmi=405866764&utm_content=405866764&utm_source=hs_email
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario